Literature DB >> 14751226

Dimerization modulates the activity of the orphan nuclear receptor ERRgamma.

Johanna Huppunen1, Piia Aarnisalo.   

Abstract

Estrogen-related receptor gamma (ERRgamma) is an orphan nuclear receptor lacking identified natural ligands. However, 4-hydroxytamoxifen and diethylstilbestrol were recently shown to bind to and inhibit ERRgamma activity. ERR activates transcription constitutively as a monomer. We show here that ERRgamma forms also dimers via its ligand-binding domain. Homodimerization enhances the transcriptional activity. In contrast, heterodimerization with the related receptor ERRalpha inhibits the activities of both ERRgamma and ERRalpha. The inverse ERRgamma agonist 4OHT further inhibits the activity of the ERRgamma-ERRalpha heterodimer, indicating that 4OHT may modulate ERRalpha signaling via ERRgamma. Receptor dimerization thus modulates the transcriptional activities of ERRs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751226     DOI: 10.1016/j.bbrc.2003.12.194

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Orphan nuclear receptor estrogen-related receptor γ (ERRγ) is key regulator of hepatic gluconeogenesis.

Authors:  Don-Kyu Kim; Dongryeol Ryu; Minseob Koh; Min-Woo Lee; Donghyun Lim; Min-Jung Kim; Yong-Hoon Kim; Won-Jea Cho; Chul-Ho Lee; Seung Bum Park; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

Review 2.  Adopting new orphans into the family of metabolic regulators.

Authors:  Sarah Hummasti; Peter Tontonoz
Journal:  Mol Endocrinol       Date:  2008-02-07

3.  CLARITY-BPA: Effects of chronic Bisphenol A exposure on the immune system: Part 1 - Quantification of the relative number and proportion of leukocyte populations in the spleen and thymus.

Authors:  Jinpeng Li; Anthony Bach; Robert B Crawford; Ashwini S Phadnis-Moghe; Weimin Chen; Shawna D'Ingillo; Natalia Kovalova; Jose E Suarez-Martinez; Jiajun Zhou; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicology       Date:  2018-02-08       Impact factor: 4.221

4.  The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein.

Authors:  J L Fiori; M Sanghvi; M P O'Connell; S M Krzysik-Walker; R Moaddel; M Bernier
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Interplay between estrogen-related receptor alpha (ERRalpha) and gamma (ERRgamma) on the regulation of ERRalpha gene expression.

Authors:  Zhiping Zhang; Christina T Teng
Journal:  Mol Cell Endocrinol       Date:  2006-12-08       Impact factor: 4.102

6.  Identification and characterization of estrogen receptor-related receptor alpha and gamma in human glioma and astrocytoma cells.

Authors:  Mukesh K Gandhari; Chester R Frazier; Julia S Hartenstein; Jean-Francois Cloix; Michel Bernier; Irving W Wainer
Journal:  Mol Cell Endocrinol       Date:  2009-10-12       Impact factor: 4.102

7.  Increased expression of estrogen-related receptor β during adaptation of adult cardiomyocytes to sustained hypoxia.

Authors:  Kathryn F Cunningham; Gyda C Beeson; Craig C Beeson; Paul J McDermott
Journal:  Am J Cardiovasc Dis       Date:  2016-05-18

8.  An autoregulatory loop controlling orphan nuclear receptor DAX-1 gene expression by orphan nuclear receptor ERRgamma.

Authors:  Yun-Yong Park; Seung-Won Ahn; Hye-Jin Kim; Jin-Man Kim; In-Kyu Lee; Heonjoong Kang; Hueng-Sik Choi
Journal:  Nucleic Acids Res       Date:  2005-11-28       Impact factor: 16.971

9.  Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells.

Authors:  Elizabeth W Lapensee; Traci R Tuttle; Sejal R Fox; Nira Ben-Jonathan
Journal:  Environ Health Perspect       Date:  2008-10-08       Impact factor: 9.031

Review 10.  The NR3B subgroup: an ovERRview.

Authors:  Annie M Tremblay; Vincent Giguère
Journal:  Nucl Recept Signal       Date:  2007-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.